Literature DB >> 26853272

Mineral and bone disorders: Targeting CYP24A1.

Susan J Allison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26853272     DOI: 10.1038/nrneph.2016.16

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.

Authors:  Xiuying Bai; Dengshun Miao; Sophia Xiao; Dinghong Qiu; René St-Arnaud; Martin Petkovich; Ajay Gupta; David Goltzman; Andrew C Karaplis
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.